Key result
Adiponectin is a novel adipocytokine with antidiabetic, antiatherosclerotic, and antiinflammatory functions, whose plasma levels decrease with the accumulation of visceral adipose tissue.
Design
Review
Authors
Loading...
Adiponectin decline may link visceral adiposity to cardiometabolic and vascular risk; supports further mechanistic and prospective studies.
This review highlights the role of adiponectin as a protective adipocytokine that links visceral adiposity to insulin resistance and vascular diseases.
Matsuzawa et al. (2003) conducted a review in Metabolic syndrome and vascular disease. Adiponectin was evaluated. Adiponectin is a novel adipocytokine with antidiabetic, antiatherosclerotic, and antiinflammatory functions, whose plasma levels decrease with the accumulation of visceral adipose tissue.